Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Original Article

Anti-inflammatory diet and Alzheimer's disease mortality: modifiable factors across generations

Adherence to an anti-inflammatory diet is associated with lower Alzheimer's disease mortality: A modifiable risk factor in a national cohort.

The journal of prevention of Alzheimer's disease

Citation & Authors

J Prev Alzheimers Dis. 2025;12(8):100221.

Ching-Chi Hsu; Shiow-Ing Wang; Sebastian Yu; Eric S Lin; James Cheng-Chung Wei

ABSTRACT · CHINESE TRANSLATION

Translated abstract

Translated from the licensed abstract via the Chinese version. This is not an official journal translation.

background

Chronic neuroinflammation contributes to the pathogenesis of Alzheimer’s disease (AD), and diet is a modifiable influence on inflammation. The association between an anti-inflammatory diet and AD-specific mortality remains unclear.

purpose

This large nationwide cohort examined associations between adherence to an anti-inflammatory diet, measured as the proportion of total energy from anti-inflammatory foods, and AD-specific and all-cause mortality, and assessed differences by sex or race/ethnicity.

method

The analysis included 18,795 adults aged ≥18 years from the 2007–2014 US National Health and Nutrition Examination Survey. Anti-inflammatory food intake was categorized by its proportion of total energy as 0%, <5%, 5–9.99%, or ≥10%. AD-specific and all-cause deaths were ascertained through the National Death Index. Cox proportional hazards models estimated HRs and 95% confidence intervals across intake categories, adjusting for demographic, lifestyle, and health factors and stratifying by sex, race/ethnicity, and age. The AD mortality analysis was restricted to participants aged ≥45 years.

result

Compared with participants whose intake was ≥10%, the 0% group had a higher risk of all-cause mortality (HR 3.82; 95% CI 1.18–12.33). In the overall analysis, the original abstract described a decreasing trend in AD-specific mortality in the 0% group, which was not statistically significant after full adjustment; the estimate it reported was HR 3.04 (95% CI 0.74–12.46; versus the ≥10% group, p>0.05). Subgroup analyses showed an inverse association between an anti-inflammatory diet and AD mortality. Compared with the ≥10% group, men and non-Hispanic White participants with 0% intake had AD mortality HRs of 12.83 and 3.77, respectively, indicating significantly lower risk associated with anti-inflammatory diets in these populations. No significant association was observed in women or non-White participants. Even when anti-inflammatory foods supplied only ≥10% of energy, intake was associated with lower AD mortality in these subgroups and lower all-cause mortality overall.

Conclusion

Higher intake of anti-inflammatory foods was associated with lower all-cause mortality and a trend toward lower AD-specific mortality. The observed protective associations were restricted to certain populations, particularly men and non-Hispanic White participants. Even when only 10% of dietary energy came from anti-inflammatory foods, intake was associated with lower mortality in these populations, suggesting that achievable dietary changes may matter. The study supports dietary modification as a practical, low-cost intervention that may reduce AD mortality by attenuating neuroinflammation.

The original abstract’s description of the direction of risk in the 0% intake group is inconsistent with the HR of 3.04. The reported value and the original wording are explicitly retained here; please consult the original article.

Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.

Original work license:CC BY ↗;Translations are subject to the same licensing conditions.